Hyaluronic acid-modified magnetic iron oxide nanoparticles for MR imaging of surgically induced endometriosis model in rats

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Zhang, He ^a   Li, Jingchao ^b   Sun, Wenjie ^b   Hu, Yong ^b   Zhang, Guofu ^a   Shen, Mingwu ^b   Shi, Xiangyang ^b  

^a FUDAN UNIVERSITY   (China)

^b DONGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; HYALURONIC ACID MODIFIED MAGNETIC IRON OXIDE NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG; CONTRAST MEDIUM; FERRIC ION; FERRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOTRANSPLANTATION; CONTRAST ENHANCEMENT; DRUG SYNTHESIS; ENDOMETRIOSIS; FEMALE; HISTOPATHOLOGY; HYPERTHERMIA; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; IN VIVO STUDY; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SCANNER; QUANTITATIVE ANALYSIS; RAT; SENSITIVITY ANALYSIS; STAINING; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CHEMISTRY; DISEASE MODEL; ENDOMETRIUM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT;

ANIMALS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; FERRIC COMPOUNDS; HYALURONIC ACID; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84899502369     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094718     Document Type: Article

References (41)

1. Cramer D, Missmer S (2002) The epidemiology of endometriosis. Ann N Y Acad Sci 955: 11-22. (Pubitemid 34271058)
2. Benagiano G, Brosens I, Habiba M (2013) Structural and molecular features of the endomyometrium in endometriosis and adenomyosis. Human Reproduction Update. doi: 10.1093/humupd/dmt052.
3. Cornillie FJ OD, Lauweryns JM, Koninckx PR (1990) Deeply infiltrating pelvic endometriosis: histology and clinical significance. Fertil Steril 53:978-983. (Pubitemid 20208958)
4. Thomassin-Naggara I, Darai E, Cuenod CA, Fournier L, Toussaint I, et al. (2009) Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses. European Radiology 19: 1544-1552.
5. Dilks P, Narayanan P, Reznek R, Sahdev A, Rockall A (2010) Can quantitative dynamic contrast-enhanced MRI independently characterize an ovarian mass? European Radiology 20: 2176-2183.
6. Griffin N, Grant LA, Sala E (2010) Adnexal Masses: Characterization and Imaging Strategies. Seminars in Ultrasound, CT, and MRI 31: 330-346.
7. Bazot M, Gasner A, Lafont C, Ballester M, Daraï E (2011) Deep pelvic endometriosis: Limited additional diagnostic value of postcontrast in comparison with conventional MR images. European journal of radiology 80: e331-e339.
8. Kyriazi S, Collins DJ, Messiou C, Pennert K, Davidson RL, et al. (2011) Metastatic Ovarian and Primary Peritoneal Cancer: Assessing Chemotherapy Response with Diffusion-weighted MR Imaging - Value of Histogram Analysis of Apparent Diffusion Coefficients. Radiology 261: 182-192.
9. Togashi K, Nishimura K, Kimura I, Tsuda Y, Yamashita K, et al. (1991) Endometrial cysts: diagnosis with MR imaging. Radiology 180: 73-78.
10. Busard MPH, Mijatovic V, van Kuijk C, Pieters-van den Bos IC, Hompes PGA, et al. (2010) Magnetic resonance imaging in the evaluation of (deep infiltrating) endometriosis: The value of diffusion-weighted imaging. Journal of Magnetic Resonance Imaging 31: 1117-1123.
11. Kinkel K, Frei K, Balleyguier C, Chapron C (2006) Diagnosis of endometriosis with imaging: a review. European Radiology 16: 285-298. (Pubitemid 43149627)
12. Sala E, Rockall A, Rangarajan D, Kubik-Huch RA (2010) The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis. European journal of radiology 76: 367-385.
13. Xu C, Sun S (2013) New forms of superparamagnetic nanoparticles for biomedical applications. Advanced Drug Delivery Reviews 65: 732-743.
14. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26: 3995-4021. (Pubitemid 40044762)
15. Cai H, An X, Cui J, Li J, Wen S, et al. (2013) Facile Hydrothermal Synthesis and Surface Functionalization of Polyethyleneimine-Coated Iron Oxide Nanoparticles for Biomedical Applications. ACS Applied Materials & Interfaces 5: 1722-1731.
16. Li J, Zheng L, Cai H, Sun W, Shen M, et al. (2013) Facile One-Pot Synthesis of Fe3O4@Au Composite Nanoparticles for Dual-Mode MR/CT Imaging Applications. ACS Applied Materials & Interfaces 5: 10357-10366.
17. Turcheniuk K, Tarasevych AV, Kukhar VP, Boukherroub R, Szunerits S (2013) Recent advances in surface chemistry strategies for the fabrication of functional iron oxide based magnetic nanoparticles. Nanoscale 5: 10729-10752.
18. Lee N, Choi Y, Lee Y, Park M, Moon WK, et al. (2012) Water-Dispersible Ferrimagnetic Iron Oxide Nanocubes with Extremely High r2 Relaxivity for Highly Sensitive in Vivo MRI of Tumors. Nano Letters 12: 3127-3131.
19. Xu C, Sun S (2009) Superparamagnetic nanoparticles as targeted probes for diagnostic and therapeutic applications. Dalton Transactions: 5583-5591.
20. Lee N, Hyeon T (2012) Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chemical Society Reviews 41: 2575-2589.
21. Li J, He Y, Sun W, Luo Y, Cai H, et al. (2014) Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging. Biomaterials 35: 3666-3677.
22. Bazot M, Darai E, Hourani R, Thomassin I, Cortez A, et al. (2004) Deep Pelvic Endometriosis: MR Imaging for Diagnosis and Prediction of Extension of Disease1. Radiology 232: 379-389. (Pubitemid 38971276)
23. Schreinemacher MH, Backes WH, Slenter JM, Xanthoulea S, Delvoux B, et al. (2012) Towards Endometriosis Diagnosis by Gadofosveset-Trisodium Enhanced Magnetic Resonance Imaging. PLoS ONE 7: e33241.
24. Lee HJ, Lee HJ, Lee JM, Chang Y, Woo ST (2012) Ultrasmall superparamagnetic iron oxides enhanced MR imaging in rats with experimentally induced endometriosis. Magnetic resonance imaging 30: 860-868.
25. McCarthy JR, Weissleder R (2008) Multifunctional magnetic nanoparticles for targeted imaging and therapy. Advanced Drug Delivery Reviews 60: 1241-1251.
26. Wang Z, Boddington S, Wendland M, Meier R, Corot C, et al. (2008) MR imaging of ovarian tumors using folate-receptor-targeted contrast agents. Pediatric Radiology 38: 529-537.
27. Liu HL, Sonn CH, Wu JH, Lee K-M, Kim YK (2008) Synthesis of streptavidin-FITC-conjugated core-shell Fe3O4-Au nanocrystals and their application for the purification of CD4+ lymphocytes. Biomaterials 29: 4003-4011.
28. Pan B, Cui D, Sheng Y, Ozkan C, Gao F, et al. (2007) Dendrimer-Modified Magnetic Nanoparticles Enhance Efficiency of Gene Delivery System. Cancer Research 67: 8156-8163. (Pubitemid 47395151)
29. Chen Y, Chen H, Zeng D, Tian Y, Chen F, et al. (2010) Core/Shell Structured Hollow Mesoporous Nanocapsules: A Potential Platform for Simultaneous Cell Imaging and Anticancer Drug Delivery. ACS Nano 4: 6001-6013.
30. Berry CC, Wells S, Charles S, Aitchison G, Curtis ASG (2004) Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. Biomaterials 25: 5405-5413. (Pubitemid 38586755)
31. Shi X, Wang SH, Swanson SD, Ge S, Cao Z, et al. (2008) Dendrimer-Functionalized Shell-crosslinked Iron Oxide Nanoparticles for In-Vivo Magnetic Resonance Imaging of Tumors. Advanced Materials 20: 1671-1678.
32. Larsen EKU, Nielsen T, Wittenborn T, Birkedal H, Vorup-Jensen T, et al. (2009) Size-Dependent Accumulation of PEGylated Silane-Coated Magnetic Iron Oxide Nanoparticles in Murine Tumors. ACS Nano 3: 1947-1951.
33. Xie J, Xu C, Kohler N, Hou Y, Sun S (2007) Controlled PEGylation of Monodisperse Fe3O4 Nanoparticles for Reduced Non-Specific Uptake by Macrophage Cells. Advanced Materials 19: 3163-3166. (Pubitemid 350044454)
34. Chertok B, David AE, Yang VC (2010) Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intracarotid administration. Biomaterials 31: 6317-6324.
35. Li J, Zheng L, Cai H, Sun W, Shen M, et al. (2013) Polyethyleneimine- mediated synthesis of folic acid-targeted iron oxide nanoparticles for in vivo tumor MR imaging. Biomaterials 34: 8382-8392.
36. Lebovic DI, Kir M, Casey CL (2004) Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis. Fertility and sterility 82: 1008-1013. (Pubitemid 39341177)
37. Grümmer R (2006) Animal models in endometriosis research. Human Reproduction Update 12: 641-649.
38. Bae KH, Yoon JJ, Park TG (2006) Fabrication of Hyaluronic Acid Hydrogel Beads for Cell Encapsulation. Biotechnology Progress 22: 297-302.
39. Jiang G, Park K, Kim J, Kim KS, Oh EJ, et al. (2008) Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Biopolymers 89: 635-642.
40. Kamat M, El-Boubbou K, Zhu DC, Lansdell T, Lu X, et al. (2010) Hyaluronic Acid Immobilized Magnetic Nanoparticles for Active Targeting and Imaging of Macrophages. Bioconjugate Chemistry 21: 2128-2135.
41. Kumar R, Roy I, Ohulchanskky TY, Vathy LA, Bergey EJ, et al. (2010) In Vivo Biodistribution and Clearance Studies Using Multimodal Organically Modified Silica Nanoparticles. ACS Nano 4: 699-708.